Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 9 of 9

Publication Record

Connections

Health Care Costs and Cost-effectiveness in Laryngotracheal Stenosis.
Yin LX, Padula WV, Gadkaree S, Motz K, Rahman S, Predmore Z, Gelbard A, Hillel AT
(2019) Otolaryngol Head Neck Surg 160: 679-686
MeSH Terms: Adult, Cost-Benefit Analysis, Dilatation, Endoscopy, Female, Health Care Costs, Humans, Laryngostenosis, Male, Middle Aged, Quality-Adjusted Life Years, Retrospective Studies, Tracheal Stenosis, Tracheotomy
Added July 30, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.
Saumoy M, Schneider Y, Shen N, Kahaleh M, Sharaiha RZ, Shah SC
(2018) Gastroenterology 155: 648-660
MeSH Terms: African Americans, Continental Population Groups, Cost-Benefit Analysis, Early Detection of Cancer, Ethnic Groups, European Continental Ancestry Group, Female, Gastroscopy, Hispanic Americans, Humans, Male, Markov Chains, Mass Screening, Middle Aged, Quality-Adjusted Life Years, Stomach Neoplasms, United States
Added March 3, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
Cost-effectiveness of initial diagnostic strategies for pulmonary nodules presenting to thoracic surgeons.
Deppen SA, Davis WT, Green EA, Rickman O, Aldrich MC, Fletcher S, Putnam JB, Grogan EL
(2014) Ann Thorac Surg 98: 1214-22
MeSH Terms: Biopsy, Fine-Needle, Bronchoscopy, Cost-Benefit Analysis, Decision Support Techniques, Fluorodeoxyglucose F18, Humans, Lung Neoplasms, Male, Middle Aged, Positron-Emission Tomography, Quality-Adjusted Life Years, Solitary Pulmonary Nodule, Surgeons, Thoracic Surgery, Video-Assisted, Tomography, X-Ray Computed
Added October 28, 2015
0 Communities
1 Members
0 Resources
15 MeSH Terms
Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.
Shepardson D, Marks SM, Chesson H, Kerrigan A, Holland DP, Scott N, Tian X, Borisov AS, Shang N, Heilig CM, Sterling TR, Villarino ME, Mac Kenzie WR
(2013) Int J Tuberc Lung Dis 17: 1531-7
MeSH Terms: Antitubercular Agents, Computer Simulation, Cost-Benefit Analysis, Directly Observed Therapy, Drug Administration Schedule, Drug Costs, Drug Therapy, Combination, Hospital Costs, Humans, Isoniazid, Latent Tuberculosis, Models, Economic, Quality-Adjusted Life Years, Rifampin, Time Factors, Treatment Outcome, United States
Added May 29, 2014
0 Communities
1 Members
0 Resources
17 MeSH Terms
Cost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV disease.
Schackman BR, Haas DW, Becker JE, Berkowitz BK, Sax PE, Daar ES, Ribaudo HJ, Freedberg KA
(2013) Antivir Ther 18: 399-408
MeSH Terms: Adult, Antiretroviral Therapy, Highly Active, Cost-Benefit Analysis, Female, Genetic Testing, Genotype, Glucuronosyltransferase, HIV Infections, Humans, Male, Middle Aged, Quality-Adjusted Life Years
Added March 13, 2015
0 Communities
1 Members
0 Resources
12 MeSH Terms
Economic and humanistic consequences of preventable bladder tumor recurrences in nonmuscle invasive bladder cancer cases.
Lee CT, Barocas D, Globe DR, Oefelein MG, Colayco DC, Bruno A, O'Day K, Bramley T
(2012) J Urol 188: 2114-9
MeSH Terms: Administration, Intravesical, Antibiotics, Antineoplastic, Cost of Illness, Humans, Mitomycin, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Quality-Adjusted Life Years, Retrospective Studies, United States, Urinary Bladder Neoplasms
Added March 27, 2014
0 Communities
1 Members
0 Resources
11 MeSH Terms
Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.
Zeliadt SB, Etzioni RD, Penson DF, Thompson IM, Ramsey SD
(2005) Am J Med 118: 850-7
MeSH Terms: Aged, Aged, 80 and over, Cost-Benefit Analysis, Enzyme Inhibitors, Finasteride, Humans, Male, Markov Chains, Middle Aged, Models, Econometric, Prostatic Neoplasms, Quality-Adjusted Life Years, Randomized Controlled Trials as Topic, United States
Added March 5, 2014
0 Communities
1 Members
0 Resources
14 MeSH Terms
Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies.
Stringer JS, Sinkala M, Rouse DJ, Goldenberg RL, Vermund SH
(2002) Am J Public Health 92: 365-6
MeSH Terms: Anti-HIV Agents, Cohort Studies, Decision Support Techniques, Female, Fetal Death, HIV Infections, Humans, Infectious Disease Transmission, Vertical, Nevirapine, Perinatal Care, Pregnancy, Quality-Adjusted Life Years, Reproducibility of Results, Zidovudine
Added March 5, 2014
0 Communities
1 Members
0 Resources
14 MeSH Terms
The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer.
Penson DF, Stoddard ML, Pasta DJ, Lubeck DP, Flanders SC, Litwin MS
(2001) J Clin Epidemiol 54: 350-8
MeSH Terms: Activities of Daily Living, Adult, Aged, Aged, 80 and over, Analysis of Variance, Cohort Studies, Comorbidity, Educational Status, Health Status, Humans, Income, Insurance Coverage, Insurance, Health, Male, Marital Status, Middle Aged, Neoplasm Staging, Poverty, Prostatic Neoplasms, Quality of Life, Quality-Adjusted Life Years, Registries, Retrospective Studies, San Francisco, Treatment Outcome
Added March 5, 2014
0 Communities
1 Members
0 Resources
25 MeSH Terms